Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Adastra

38 redundancies as Adastra Access files for administration

'Significant operational, health and safety and financial challenges' resulted in insurmountable trading losses

Insider UK · Jun 21, 2023

Adastra Steps Into Magic Mushrooms! Gets Dealer's License For Psilocybin And Psilocin

Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX) (FRA:D2EP) has received its Controlled Drug and Substances Dealer's License on August 24, 2022. This license allows Adastra to process psilocybin and psilocin, the active compounds derived from psychedelic mushrooms.

Benzinga · Aug 31, 2022

Cannabis Movers & Shakers: OnPoint Laboratories, Neptune Wellness, Adastra Holdings & Cannaverse Technologies

OnPoint Laboratories Names Samuel Richard CEO & Equity Partner OnPoint Laboratories has appointed Samuel Richard to serve as CEO and equity partner. Richard succeeds Jeff Cardot, founder and current CEO, as part of a planned transition.

Benzinga · May 20, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Adastra Holdings Appoints Smoke Wallin As New Director

Adastra Holdings Ltd. (OTCPK: XTXXF) (FRA: D2EP) appointed Smoke Wallin to the company's board of directors. Wallin Responds

Benzinga · May 16, 2022

Adastra Holdings Reports Record Revenue In 2021, Here Are The Details

Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX) (FRA:D2EP) has filed its consolidated financial statements and related management discussion and analysis for the year ended December 31, 2021.

Benzinga · May 4, 2022

Adastra Submits Medical Sales License Application And Engages IR Labs To Provide Investor Relations Services

Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX) (FRA:D2EP) submitted medical sales license application to Health Canada on April 1, 2022. A medical sales license would permit Adastra to perform the following activities:

Benzinga · Apr 11, 2022

Psyched: Third Michigan City Decriminalizes Psychedelics, MindMed Reports $133M Cash Position, Real Brands To Enter The Space

The psychedelics legislative landscape continues to move forward with Hazel Park, Michigan enacting decriminalization measures for naturally-produced psychedelic molecules, becoming the third city in the state to do so after Ann Arbor and Detroit. In Utah, Governor Cox signed a psychedelics research bill into law and positive legislation around psilocybin is continuing…

Benzinga · Mar 29, 2022

Read news from The Economist, FT, and more,
with one subscription

Adastra Holdings Approved For Dealer's License For Psilocybin, Psilocin, MDMA, DMT, 5-MeO-DMT & LSD

Adastra Holdings Ltd. (OTCPK: XTXXF) (CSE: XTRX) (FRA: D2EP) recently completed the submission of its application for a controlled drugs and substances dealer's license. What Does It Mean?

Benzinga · Mar 25, 2022

Adastra Holdings To Bring Zyre Brands Cannabis Vapes To Canadian Market

Adastra Holdings Ltd. (CSE:XTRX) (FRANKFURT:D2EP) entered into a private label manufacturing agreement with Zyre Brands Corp. under which Adastra will manufacture custom-formulated cured resin vape products to sell under the Zyre brand in the Canadian adult-use market.

Benzinga · Mar 15, 2022

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Psychedelic Spotlight

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.